Eli Lilly and Company (LLY · NYSE)

LLY · MARKET VIEW

Market view · as of Jun 15, 2026

Revenue (TTM)
$72.25B
+55.5% YoY
Gross margin
82.8%
EPS (latest q)
$8.55
vs $6.79 est · beat
52-wk position
94.8%
-2.4% vs 52w high · +12.7% 1mo

Price (last ~year)

Eli Lilly and Company (LLY) maintains a $1.01 trillion market capitalization, having reported a March 2026 quarterly earnings beat of $8.55 per share against an estimated $6.79. Revenue for the period reached $19.80 billion, contributing to year-over-year revenue growth of 55.5% and earnings growth of 169.9%. The stock recently closed at $1133.00, representing 94.8% of its 52-week price range.

Valuation

Market cap
$1.01T
P/E
40.32
PEG
1.519
P/B
32.38
P/S
13.98
EV/EBITDA
28.95
Beta
0.517
Analyst target
$1215.79

Quality & returns

Gross margin
82.8%
Operating margin
49.4%
Profit margin
35.0%
ROE
107.5%
ROA
20.7%

Price movement

Last
$1133.00
1-month
+12.7%
3-month
+23.6%
RSI (14)
62
vs SMA200
+18.5%
52-wk position
94.8% -2.4% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-03-31$19.80B$8.85B$7.40B$9.69B
2025-12-31$19.29B$8.78B$6.64B$8.39B
2025-09-30$17.60B$8.39B$5.58B$7.88B
2025-06-30$15.56B$7.13B$5.66B$7.50B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots